Cancer scientists have designed the first molecular test to predict which bladder cancer patients may have cancer involvement in their lymph nodes at the time of surgery - which could help doctors determine which patients are good candidates for pre-surgical, or neo-adjuvant, chemotherapy. The test analyzes 20 genes on tumor biopsies, according to a paper published online in Lancet Oncology...
Read from Source
|
